Pharmacokinetic Study of MIN-101 in Healthy Subjects

Summary

The aim of the study is to assess how MIN-101 is taken up by the body when given in different amounts and in different formulations. The drug will be given as a single dose in Part 1 of the study and during Part 2 of the study as multiple dose, once daily for 7 days. The ultimate aim is to find an optimal formulation which can be developed as a once daily dose for the treatment of schizophrenia.

Timeline

Start

2014-09

Primary completion

2015-02

Completion

2015-02

Drugs

Indications